临床试验/NCT00375596

NCT00375596撤回2 期

Study Withdrawn Prior to Determining Official Title

Bausch & Lomb Incorporated0 个研究点开始时间: 2006年9月13日最近更新: 2015年2月20日

适应症

试验速览

阶段: 2 期
状态: 撤回
发起方: Bausch & Lomb Incorporated
主要终点: Safety and efficacy of a new allergy medication

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

This study will evaluate the safety and efficacy of a new allergy medication

详细描述

Study withdrawn prior to determining study details

研究设计

研究类型: Interventional
干预模型: Parallel

入排标准

年龄范围: 6 Years 至 —（Child, Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Be at least 6 years of age, of any race, or either gender.
•Have a positive allergic history of ocular allergies and a positive skin test reaction to cat hair/dander, ragweed, tree and/or grass pollen within the past 24 months.
•Have a calculated best-corrected visual acuity of 0.6 logMar or better in each eye as measured using an ETDRS chart.
•Positive bilateral CAC reaction at Visit 1 & 2.

排除标准

•Have any known contraindications, allergies, or sensitivities to the use of any of the study medications, or their components.
•Any ocular condition that, in the opinion of the investigator, could affect the subject's safety or trial parameters
•Manifest signs or symptoms of clinically active allergic conjunctivitis in either eye at the baseline slit-lamp exam of any visit

结局指标

主要结局

Safety and efficacy of a new allergy medication

时间窗: 0

STUDY WITHDRAWN PRIOR TO OUTCOME DETERMINATION

次要结局

未报告次要终点

研究者

发起方

Bausch & Lomb Incorporated

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

Intra-retinal arterial fibrinolysisCentral retinal artery occlusion

JPRN-jRCTs031180441Kadonosono Kazuaki3

已完成

不适用

A prospective feasibility study of allogeneic hematopoietic stem cell transplantation using once daily intravenous busulfan and fludarabine as conditioning regimehematological malignancy

JPRN-UMIN000029115Osaka International Cancer Institute

已完成

1 期

A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate CancerBone MetastasesProstate Cancer

NCT00958477Merck KGaA, Darmstadt, Germany26

招募中

2 期

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)Bronchiolitis Obliterans SyndromeBronchiolitis ObliteransLung DiseasesChronic Graft Versus Host Disease

NCT05922761Dana-Farber Cancer Institute45

已完成

不适用

A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein HydrolysatesCow Milk Allergy

NCT01940068United Pharmaceuticals86